NC
EVFM

NewSquare Capital’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

NewSquare Capital’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-44
Closed -$3K – 339
2019
Q3 		$3K Hold
44
– – ﹤0.01% 248
2019
Q2 		$4K Buy
+44
New +$3.41K ﹤0.01% 308

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LFS
Link Fund Solutions London, United Kingdom $157M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewSquare Capital's EVFM Position: Q4 2019 in Review

NewSquare Capital sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2019, closing a stake of 44 shares — an estimated $3K sold.

NewSquare Capital first reported a position in EVFM in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 42 funds tracked by Wall St. Rank hold EVFM as of Q4 2019.

  • NewSquare Capital reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • NewSquare Capital sold 44 Evofem Biosciences, Inc. Common Stock shares in Q4 2019, an estimated $3K.
  • NewSquare Capital first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • NewSquare Capital's Evofem Biosciences, Inc. Common Stock position peaked at $4K in Q2 2019.
  • 42 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2019.

Based on NewSquare Capital's 13F filing for Q4 2019, filed 10 Jan 2020.